Bausch Health Companies (BHC) Cost of Revenue (2009 - 2025)

Bausch Health Companies (BHC) has 17 years of Cost of Revenue data on file, last reported at -$4.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 94.52% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at $43.0 million (up 4.88% YoY), and the FY2022 full-year result was $40.0 million, down 9.09% from the prior year.
• Cost of Revenue declined to -$4.0 million in Q4 2025, from $14.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $640.0 million in Q2 2023 to a low of -$1.7 billion in Q4 2021.
• A 5-year average of $45.1 million and a median of $23.5 million in 2025 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue surged 7000.0% in 2022 and sank 143.33% in 2024, its largest moves.
• Tracing BHC's Cost of Revenue over 5 years: stood at -$1.7 billion in 2021, then rose by 3.59% to -$1.6 billion in 2022, then surged by 98.17% to -$30.0 million in 2023, then slumped by 143.33% to -$73.0 million in 2024, then surged by 94.52% to -$4.0 million in 2025.
• Business Quant data shows BHC's Cost of Revenue at -$4.0 million in Q4 2025, $14.0 million in Q3 2025, and $33.0 million in Q2 2025.